A Redox-responsive Prodrug Nanogel of TLR7/8 Agonist for Improved Cancer Immunotherapy
Kai‐Shuo Wang, Yufeng Jin, Qi‐Song Tong, Yong‐Cong Huang, Zhenlin Gao, Sui-Juan Zheng, Jingyang Zhang, Jun Wang, Jin‐Zhi Du
Topics & Concepts
ProdrugTLR7NanogelImmunotherapyImmune systemCancer researchCancer immunotherapyTumor microenvironmentDrug deliveryChemistryPharmacologyImmunologyMedicineToll-like receptorInnate immune systemOrganic chemistryImmune cells in cancerImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers